In patients with type 2 diabetes inadequately controlled with metformin, adding a novel nonpeptide oral GLP-1 receptor agonist to metformin boosts glycemic control.

New studies suggest oral GLP-1 drugs may curb food cravings through unique brain pathways and could help treat alcohol use disorder.

Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep ...

How GLP-1 Drugs Work GLP-1s and Your Stomach Oral Semaglutide Small-Molecule Drugs A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like ...

Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist. The glucagon-like peptide-1 (GLP-1) class has transformed ...

Share on Pinterest A new oral GLP-1 drug effectively lowers blood sugar, boosts weight loss in type 2 diabetes, according to recent trial data. Image credit: Yana Iskayeva/Getty Images About 12% of ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...

G lucagon-like peptide-1 receptor agonists, more commonly known as GLP-1s, have become popular treatments for obesity in recent years. These medications help people with obesity lose weight; improve ...

For the past two years, GLP-1 medications have been a fixture of consumer trend analysis, discussed by everyone from CNBC to sell-side strategists to management consultants. Real apparel expenditure ...